Dabigatran Impurity 42 | CAS 1369510-38-2 - Request Quote
Dabigatran Impurity 42
| SZ CAT No: | SZ-D012150 |
| CAS No | 1369510-38-2 |
| Mol.F. | C17H20N4O3 |
| Mol.Wt. | 328.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Dabigatran Impurity 42 is chemically Methyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate. Dabigatran Impurity 42 is supplied with detailed characterization data compliant with regulatory guideline. Dabigatran Impurity 42 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Dabigatran.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1369510-38-2
Purchase 1369510-38-2
Order 1369510-38-2
Enquire 1369510-38-2
price of 1369510-38-2
1369510-38-2 Supplier
1369510-38-2 Manufacturer
1369510-38-2 Exporter
buy high quality Dabigatran Impurity 42
Purchase Dabigatran Impurity 42
Dabigatran Impurity 42 suppliers
Dabigatran Impurity 42 manufacturers
Dabigatran Impurity 42 price
Order Dabigatran Impurity 42
Enquire Dabigatran Impurity 42
Dabigatran Impurity 42 cost
Dabigatran Impurity 42 Supplier
Dabigatran Impurity 42 Distributor
Dabigatran Impurity 42 for Method Validation
Dabigatran Reference Standard
Dabigatran Impurity 42 for ANDA Filing
Dabigatran Impurity 42 for Forced Degradation Studies
Dabigatran Impurity 42 Identification Standards
Dabigatran Impurity 42 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.